A wide variety of medical conditions characterized by muscular spasticity are frequently treated with botulinum toxin type A. Hemifacial muscle hypertrophy and speech impairments caused by spasmodic episodes are among the diseases mentioned above. In recent years, there has been a growing trend in the utilization of a particular active ingredient within the realm of minimally invasive aesthetics. This substance has gained popularity for its efficacy in addressing dynamic wrinkles that arise from excessive facial muscle movements, specifically in areas such as the forehead, frown lines, corners of the eyes, and smile lines that expose the gums. Additionally, it has shown promise in managing hyperhidrosis in the hands and armpits, as well as aiding in the treatment of cosmetic scars. The application of micro-injections containing this active ingredient has thus contributed to significant advancements in the field of cosmetic rejuvenation. Furthermore, we aim to enhance and expand the existing knowledge and guidelines pertaining to the utilization of Botulium toxin type A. This includes its significance in the field of general surgery, specifically in the context of supporting hernias of the abdominal wall and mitigating the occurrence of recurrent complications. Furthermore, we seek to explore its applications in preoperative, intraoperative, and postoperative settings for managing muscle spasms and alleviating pain symptoms. The data has been gathered from both local and international research sources and then disseminated via esteemed academic publications during the last five years. The content aligns with contemporary trends and has potential for broader use in disease treatment via research cooperation between therapeutic and cosmetic plastic specialties, therefore maximizing the advantages for patients. Research is currently being done in small quantities and is not yet widely available in domestic publications. The authors aim to present novel insights and current applications being employed at the center, with the intention of facilitating knowledge acquisition among colleagues. The focus of this information pertains to the utilization of Botulinum toxin type A within the cosmetic industry. These minimally invasive applications facilitate the management of surgical conditions in addition to disorders associated with muscular tension.